Search the Newsreel

Addex Therapeutics Ltd (ADXN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Addex Therapeutics Ltd (ADXN), noting that no earnings forecast score is currently available, contrasting with the industry average. It highlights an analyst-rated target price of $30.00, suggesting a significant upside. The report also includes peer comparisons for …

Addex Therapeutics Ltd (ADXN) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

Trading Systems Reacting to (ADXN) Volatility

This article analyzes Addex Therapeutics Ltd (NASDAQ: ADXN) volatility, identifying a near-term strong sentiment challenging persistent mid and long-term weakness. It details institutional trading strategies, including long, breakout, and short positions, alongside multi-timeframe signal analysis, emphasizing resistance testing and risk-reward setups.

Addex Therapeutics Ltd Revenue Breakdown – SIX:ADXN

Addex Therapeutics Ltd (SIX:ADXN) reported its revenue breakdown, highlighting Switzerland as its largest contributor. The company generated 172.86K CHF from Switzerland last year, a decrease from 410.04K CHF the previous year. This breakdown provides insight into the company's financial performance by geographical source.

Addex Therapeutics Ltd (ADXN) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Addex Therapeutics Ltd (ADXN), highlighting its current risk score of 1.91 within the Biotechnology & Medical Research industry. Key metrics include a beta of 1.51, indicating higher volatility than the S&P 500, and various return, drawdown, and …

Addex Therapeutics Ltd (ADXN) Financial Health: Profitability & Balance Sheet Analysis

This article provides an analysis of Addex Therapeutics Ltd's (ADXN) financial health, noting its current financial score of 5.77 and ranking it 322 out of 384 in the Biotechnology & Medical Research industry. It identifies the company's financial status as stable but points out …

Addex Therapeutics Ltd (ADXN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Addex Therapeutics Ltd (ADXN), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. As of July 28, 2026, the stock has a price momentum score of 3.53 and is trading …

Addex Therapeutics Ltd (ADXN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey focuses on Addex Therapeutics Ltd (ADXN) and its revenue breakdown by business segments and regions. However, the article states that the relevant data for these breakdowns have not yet been disclosed by the company. It provides current stock information for …

Addex Therapeutics Ltd (ADXN) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of the dividend and stock split history for Addex Therapeutics Ltd (ADXN). It notes that the company has not distributed any dividends over the past five years. The article also details several stock merger events that occurred on October …

Addex Therapeutics Ltd Revenue Breakdown – GETTEX:APE

This article provides a revenue breakdown for Addex Therapeutics Ltd (APE) on GETTEX. It highlights that Switzerland was the largest contributor to the company's revenue, with 185.65K EUR in the last year, a decrease from 436.13K EUR the year prior. The data is presented …

Addex Therapeutics Ltd Sponsored ADR Revenue Breakdown – MUN:APE1

This article provides a revenue breakdown for Addex Therapeutics Ltd Sponsored ADR (MUN:APE1), highlighting that the largest contribution to its revenue came from Switzerland. In the last year, Switzerland accounted for 177.22K EUR, a decrease from 449.76K EUR in the previous year. The data …

ADXN|Addex Therapeutics Ltd|Price:6.160|Chg%:+0.289

This article provides a comprehensive stock analysis of Addex Therapeutics Ltd (ADXN), highlighting its relatively healthy fundamentals, significant growth potential, and fair valuation within the Biotechnology & Medical Research industry. It notes low institutional ownership and an analyst target price of $30.00, suggesting a …

Addex Therapeutics Ltd (ADXN) Institutional Confidence

This article provides an analysis of institutional confidence in Addex Therapeutics Ltd (ADXN), including recent shareholding changes among key institutional investors. The company's stock closed at $5.870 with a 2.98% increase. The data details institutional shareholding and activity, showing some institutions increasing their stake …

How Addex Therapeutics Ltd (ADXN) Affects Rotational Strategy Timing

Addex Therapeutics Ltd (ADXN) is showing stable neutral readings in shorter horizons, potentially easing a long-term weak bias. The article details institutional trading strategies including long, breakout, and short setups, along with a multi-timeframe signal analysis indicating support and resistance levels. An exceptional 47.5:1 …

Addex Therapeutics Q1 2024 Earnings: Continued R&D Investment Drives Net Loss; Stock Declines - Revenue Guidance Range

Enterprise value to EBITDA forward of Addex Therapeutics Ltd – SWB:APE

This article provides the enterprise value to EBITDA forward for Addex Therapeutics Ltd (SWB:APE). It appears to be a financial snapshot or data point from a trading platform, indicating market status and offering various financial tools and data. The content highlights the financial metric …

Price to sales forward of Addex Therapeutics Ltd – BX:APE

The article focuses on the "Price to sales forward" metric for Addex Therapeutics Ltd (BX:APE). It presents a placeholder for this financial data over various periods, showing value, change, and percentage change. This indicates the article is a data point page from TradingView, specifically …